Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Mini Reviews in Medicinal Chemistry|February 23, 2018
Recent Advances in Development of Polyphenols as Anticancer AgentsSreekanth Thota, Daniel Alencar Rodrigues, Eliezer J Barreiro
Current Topics in Medicinal Chemistry|October 15, 2021
Advances in the Design and Development of PROTAC-mediated HDAC DegradationDaniel Alencar Rodrigues, Andrew Roe, Darren Griffith, et al.
Science Translational Medicine|December 8, 2022
The path to venetoclax resistance is paved with mutations, metabolism, and moreGraeme P Sullivan, Lyndsey Flanagan, Daniel Alencar Rodrigues, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate CancerFabiana Sélos Guerra, Daniel Alencar Rodrigues, Carlos Alberto Manssour Fraga, et al.
International Journal of Biological Macromolecules|October 2, 2015
Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexesSreekanth Thota, Srujana Vallala, Rajeshwar Yerra, et al.
European Journal of Medicinal Chemistry|February 19, 2026
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotidesDaniel Alencar Rodrigues, Gustavo Salgado Pires, Urbi Roy, et al.
Chemical Biology & Drug Design|October 26, 2017
Structural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40)Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Thayssa Tavares da Silva Cunha Ferreira, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding GroupsGustavo Salgado Pires, Heber Victor Tolomeu, Daniel Alencar Rodrigues, et al.
Chemmedchem|April 26, 2026
Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer TherapyLara Luzietti, Gustavo Salgado Pires, Ana Ryan, et al.
Biomolecules|August 26, 2022
Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted <i>N</i>-arylpiperazine Derivatives Characterized as D<sub>2</sub>/D<sub>3</sub> Receptor Ligands, Candidates for the Treatment of Neurodegenerative DiseasesThayssa Tavares da Silva Cunha, Rafaela Ribeiro Silva, Daniel Alencar Rodrigues, et al.
Pageof 2